Archive - July 2023
Phathom Pharmaceuticals Announces FDA Acceptance of NDA Resubmission for Vonoprazan for Erosive GERD
Superagers Have Faster Movement Speed Than Typical Older Adults
Capivasertib in Combination with Faslodex Granted Priority Review in the US for Patients with Advanced HR-Positive Breast Cancer
Oral Contraceptive Use May Increase Risk for Depression
Pay for Performance Programs Cut Antibiotic Rx at Safety-Net Hospitals
Aldeyra Therapeutics Announces Achievement of Statistical Significance for Primary Endpoint and All Secondary Endpoints in Phase 3 INVIGORATE‑2 Trial of Reproxalap in Allergic Conjunctivitis
GSK Announces Extension of FDA Review Period for Momelotinib
How Much of a Difference Is 988 Making a Year After Its Launch?